We and others have also established unique in vivo manipulating systems including Zoledronate (ZOL) plus interleukin (IL)-2 to remarkably active and expand Vγ2Vδ2 T cells for immune interventions against TB infections or cancers [7,8]. The gene discussed is IL2; the disease is cancer.